Management of Bradycardia in Acute Myocardial Infarction

Initial Management

The American College of Cardiology recommends IV atropine 0.5-0.6 mg as the initial management for symptomatic sinus bradycardia with hypotension in acute MI, particularly effective for inferior MI with bradycardia and hypotension 1, 2
The typical starting dose of atropine is 0.5-0.6 mg to avoid paradoxical effects seen with lower doses, with a strength of evidence supporting its effectiveness in this setting 1
Atropine can be repeated every 3-5 minutes if needed (maximum total dose 2-3 mg) 1, 2

Volume expansion with normal saline may be considered if hypotension persists after atropine administration, with leg elevation also helping to improve venous return 1
Transcutaneous pacing is indicated for symptomatic bradycardia unresponsive to atropine, particularly useful for patients with acute MI receiving thrombolytic therapy 3
Epinephrine is the first-line vasopressor for treating bradycardia with hypotension when atropine and transcutaneous pacing fail or are not available, with a dosage of 2-10 mcg/min IV or 0.1-0.5 mcg/kg/min IV titrated to desired effect 4
Dopamine may be considered as an alternative to epinephrine, with a dosage of 5-20 mcg/kg/min IV, starting at 5 mcg/kg/min, and is best for patients with low risk of tachyarrhythmias and absolute or relative bradycardia 2, 5
Isoproterenol may be used in specific situations, with a dosage of 20-60 mcg IV bolus followed by doses of 10-20 mcg, or infusion of 1-20 mcg/min, and monitoring for potential development of ischemic chest pain is recommended 2

Atropine may cause adverse effects such as ventricular tachyarrhythmias, excessive tachycardia, and central nervous system effects with repeated doses, highlighting the need for careful monitoring 1
Doses of atropine less than 0.5 mg should be avoided as they may paradoxically worsen bradycardia, with a recommended total cumulative dose limit of 2-2.5 mg over 2.5 hours to minimize adverse effects 1, 3
High doses of dopamine (>20 mcg/kg/min) should be avoided as they may cause arrhythmias 2

Atropine should not be used in heart transplant patients without evidence of autonomic reinnervation 2
Adrenergic blockers should not be used in cocaine-induced bradycardia and hypotension 6
Norepinephrine is the first-choice vasopressor for most cases of shock 5
Dopamine should only be used in highly selected patients with low risk of tachyarrhythmias and bradycardia 5
Epinephrine is preferred over nitroprusside for bradycardia with hypotension after MI, as nitroprusside may decrease regional blood flow 7
Transcutaneous pacing should not be delayed in severely symptomatic patients while waiting for medications to take effect 3

Bradycardia in inferior MI is often due to increased vagal tone or ischemia of the AV node, with atropine being particularly effective in this setting as it blocks vagal effects 1
Atropine is beneficial for inferior MI with symptomatic AV block at nodal level 3
However, caution is advised when using atropine in acute MI as it may reduce protective parasympathetic tone 3